Sign In
search

Conference Abstracts

Below is the list of abstracts of research that was conducted as part of the Collaboration for AIDS Vaccine Discovery and presented at international conferences. Please click on the title to see more information about the abstract.

  

 Conference Abstracts
Expand/Collapse CAVD Grantee : Greenberg MIL ‎(5)
Blattman, J
The Problems with Persistent Viral InfectionsUse SHIFT+ENTER to open the menu (new window).
Workshop on the Immunological Basis of Vaccine Efficacy 2009 - Seattle
Blattman, J
Use of Retinoic Acid as an Adjuvant during Vaccination Results in Increased Central Memory T cells and also Imprints Gut Mucosal Homing Properties to Memory T CellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Greenberg, P
Creating a mouse model for human immune responses: Transferring human genes rather than human cellsUse SHIFT+ENTER to open the menu (new window).
Grand Challenge Meeting - 2009
Tan, X
Retinoic acid as an adjuvant to imprint mucosal homing properties to vaccine-induced T cellsUse SHIFT+ENTER to open the menu (new window).
American Association of Immunology 2009 - Seattle
Tan, X
Retinoic acid as an adjuvant to imprint mucosal homing properties to vaccine-induced T cells Use SHIFT+ENTER to open the menu (new window).
International Congress of Mucosal Immunology 2009 - Boston
Expand/Collapse CAVD Grantee : Haynes VDC ‎(23)
Alam, S
Phospholipid binding and neutralization by anti-gp41HIV-1 Envelope antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Alam, SM
The role of lipid reactivity of HIV-1 gp41 membrane proximal antibodies in neutralization of HIV-1: Novel liposome based immunogen designUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Chen, W
Human domain antibodies targeting conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizersUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Chen, W
Monoclonal antibodies from patient with acute HIV-1 infection Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Davis, KL
HIV-2/HIV-1 Envelope Chimeras Detect High Titer Broadly Reactive HIV-1 V3-Specific Antibodies in Human PlasmaUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Desaire, H
Glycopeptide analysis of individual glycosylation sites of HIV envelope oligomers that induce breadth in neutralizing antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Desaire, H
Glycosylation: An important factor in Env diversityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Dimitrov, DS
All Known Cross-reactive HIV-1 Neutralizing Antibodies Are Highly Divergent from Germline and their Elicitation May Require Prolonged Periods of TimeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Geonnotti, A
Endotoxin-mediated Inhibition of HIV-1 in Peripheral Blood Mononuclear Cells but Not in TZM-bl Cells: A Cautionary Note for Neutralizing Antibody AssaysUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Holl, T
Murine B cells that bind to neut 2F5 MPER epitope frequent in immature B-cell compartment, undetect in mature splenic poolsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Holl, TM
Generation of Robust Antibody Responses to HIV-1 Membrane Proximal External Region (MPER) AntigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Holl, TM
Generation of Antibody Responses to HIV-1 Membrane Proximal External Region (MPER) AntigenUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Kong, R
Epitope Mapping of Neutralizing Antibody 1.7A on the Human Immunodeficiency Virus Type 2 gp160 GlycoproteinUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Liao, HX
Characterization of the Plasma Cell Repertoire in Acute HIV-1 Infection (AHI)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Liu, W
Recombinant Baculovirus Derived HIV-1 Virus-Like Particles Elicit Potent Neutralizing Antibody ResponsesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Moody, MA
Anti-lipid Human Monoclonal Antibodies Inhibit HIV-1 Infection of PBMC By Binding to Host CellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Munshaw, M
A Large-Scale Analysis of Immunoglobulin Sequences Derived From Plasmablasts/Plasma Cells in Acute HIV-1 Infection SubjectsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Munshaw, S
A Large-Scale Analysis of Immunoglobulin Sequences Derived From Plasmablasts/Plasma Cells in Acute HIV-1 Infection SubjectsUse SHIFT+ENTER to open the menu (new window).
Multi-Scale Modeling of Host/Pathogen Interactions 2009 - Pittsburgh
Verkoczy, L
Characterization of B cell superantigen activity by membrane proximal external region 2F5 epitope in HR2 peptide-immunized miceUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Verkoczy, L
Immunological Tolerance Prevents the Expression of a Broadly Reactive Neutralizing HIV-1 AntibodyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Wiehe, K
Simulation of an MPER Peptide Samples Epitope Conformations of Two Broadly Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Xiao, X
Guiding the immune system through complex maturation pathways – a novel multi-immunogen approach for elicitation of known broadly neutralizing antibodies Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Zhang, M
Cross-Reactive HIV-Neutralizing Human Monoclonal Antibody which Recognizes Novel Conformational Epitope on gp41, Lacks Reactivity against Self AntigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Expand/Collapse CAVD Grantee : Ho VDC ‎(4)
Franco, D
Evaluation of the Yellow Fever Virus Vaccine Strain 17D as a New Vector for HIV-1 Vaccine DevelopmentUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Franco, D
Immunogenicity Studies of Chimeric Yellow Fever 17D Viruses Carrying HIV-1 p24 Antigen Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Vasan, S
Safety, Tolerability and Acceptability of Electroporation to Deliver ADVAX, a Clade C/B’ DNA-Based Candidate HIV-1 Vaccine, to Healthy VolunteersUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Vasan, S
In Vivo Electroporation Enhances the Immunogenicity of ADVAX, a DNA-based HIV-1 Vaccine Candidate, in Healthy VolunteersUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Koup VIMC ‎(11)
Bourne, V
Developing assays to characterise and phenotype long lived memory T cellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
De La Rosa, M
B cells do not play a major role in SIVmac239 nef-mediated protection against SIVmac239 challengeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
De La Rosa, M
B cells play a marginal role in SIV mac 239 nef-mediated protection against SIV mac 230 challengeUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Ferrari, G
Establishing PBMC Repository for T Cell Assays Optimization and Proficiency Testing in Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) Laboratories.Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Gilmour, J
Excellent concordance between IFN-gamma ELISpot results in two Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) Laboratories.Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Harari, A
Cytotoxic activity of virus-specific CD8 T-cells correlates with perforin and GrmB expression and differentiation stage but not with GrmA or GrmKUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Harari, A
Cytotoxic Activity of Virus-Specific CD8 T-Cells Correlates with Perforin and GrzB Expression and Differentiation Stage but not with GrzA, GrzKUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Huang, Y
Statistical Design and Analysis of the CAVD-VIMC Elispot Transfer Study 001 Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
McElrath, MJ
Vaccine-Induced Immunity in T-Cell Based Candidate HIV VaccinesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Pantaleo, G
Immune Correlates of Protection to HIVUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Ssemaganda, A
Developing the capacity for multifunctional lymphocyte analysis at the UVRI-IAVI laboratoryUse SHIFT+ENTER to open the menu (new window).
Uganda AIDS Conference 2008 - Entebbe
Expand/Collapse CAVD Grantee : Lehner VDC ‎(2)
Mörner A
Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaquesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Wang, Y
Allogeneic stimulation of the innate anti-viral factor APOBEC3G expression in human memory CD4+ T cells and prevention of SHIV infectivity in macaques immunized with recombinant HLA antigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Letvin VDC ‎(14)
Barouch, D
Novel Adenovirus Vector-Based Vaccines for HIV-1Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Barouch, Dan
HIV-1 Mosaic Antigens Expand Cellular Immune Breadth and Depth in Rhesus MonkeysUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Barouch, Dan
First-in-Human Phase 1 Safety and Immunogenicity of an Adenovirus Serotype 26 HIV-1 Vaccine VectorUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Bradley, RR
Hexon hypervariable regions 4-7 contain important Ad5-specific neutralizing antibody epitopesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Kaufman, DR
Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Ko, SY
Enteric adenovirus 41 vector enhances induction of intestinal cellular immunity by oral primingUse SHIFT+ENTER to open the menu (new window).
International Congress of Mucosal Immunology 2009 - Boston
Ko, SY
Development of recombinant adenovirus 28 vectors for HIV vaccinesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Maxfield, LF
Impact of Rare Adenovirus Seroprevalence on HIV-1 Acquisition in the Step StudyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Nabel, Gary J.
AIDS Vaccine Clinical Evaluation: Where Are We and Where Can We Go?Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Nabel, GJ
Prospects for a Global AIDS VaccineUse SHIFT+ENTER to open the menu (new window).
AAAS Meeting 2008 - Boston
Nabel, GJ
No Evidence for Consistent Virus-specific Immunity in Simian Immunodeficiency Virus Exposed, Uninfected Rhesus Monkeys. Use SHIFT+ENTER to open the menu (new window).
2007 Annecy
Nabel, GJ
Criteria for Advancement of Novel Vaccine CandidatesUse SHIFT+ENTER to open the menu (new window).
Keystone 2008 - Banff
Rhee, EG
Adaptive immune responses elicited by recombinant adenovirus vectors exhibit partial MyD88 dependenceUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Wu, L
Development of Outer Domain Env Immunogens to Elicit Broadly Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Expand/Collapse CAVD Grantee : McElrath VDC ‎(8)
Andersen-Nissen, E
Characterizing the innate immune response in HVTN 071, a trial using MRKAd5 gag/pol/nef from the STEP studyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Bhardwaj , N
Suppression of human dendritic cell function during acute HIV infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Manches, O
HIV-activated plasmacytoid dendritic cells induce regulatory T cells through an indoleamine 2,3 dioxygenase dependent mechanismUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Manches, O
HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanismUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Pulendran, B
Innate control of adaptive immunity to vaccines and pathogensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Seder, R
Primary Immunization Influences the Magnitude, Quality and Breadth of Gag Specific T Cell Responses Following an rAd-5 BoostUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Vogt, J
Development of an Ad5 ELISA: Beyond Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Zak, D
Application of systems biology to identify predictors of HIV Vaccine ImmunogenicityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Expand/Collapse CAVD Grantee : Montefiori VIMC ‎(28)
Bandawe, G
Genetic characterization and determination of multiplicity of infection using single genome amplification of recently transmitted HIV-1 env variants from a cohort with multiple circulating HIV-1 subtypes in Mbeya, TanzaniaUse SHIFT+ENTER to open the menu (new window).
IAS 2009 - Cape Town
Binley, J
Profiling the Specificity of Neutralizing Activity in a Panel of HIV+ Plasmas from Subtypes B and C Chronic InfectionsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Binley, JM
Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donorsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Borges, AR
Recombination of HIV-1 gp160 clones with viral backbone DNA through co-transfection to produce pseudoviruses can create replication competent virusesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Bronwen, E
Generation of multiple HIV-1 subtype C envelope single-genome amplification (SGA) products from recent infection cervico-vaginal lavage samplesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Brown, BK
Characterization of the influence of PBMC donor parameters on HIV-1 PBMC neutralization assay variability: implications for assay standardizationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Brown, BK
Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assaysUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Chenine, A-L
Full-length IMC expressing Renilla Luciferase for neutralization assay using PBMCUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Crooks, ET
Relationship of HIV-1 and SIV Envelope Glycoprotein Trimer Occupation and NeutralizationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Eller, LA
Breadth and Magnitude of Neutralizing Antibody Responses in Subjects Infected with HIV-1 Subtype D or D Containing Recombinants in Rakai District, UgandaUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Geonnotti, A
Endotoxin-mediated Inhibition of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells but Not in TZM-bl Cells: A Cautionary Note for Neutralizing Antibody AssaysUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Gnanakaran, S
Genetic signature analysis identifies the CD4i region of gp120 as a determinant of broadly NAb responses in HIV-1-infected individualsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Kulkarni, S
Highly Complex Neutralization Determinants on a Monophyletic Lineage of Newly Transmitted Subtype C HIV-1 Env Clones from IndiaUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Madiga, M
Development of intra- and inter-subtype cross-neutralizing antibodies in HIV-1 subtype C infection Use SHIFT+ENTER to open the menu (new window).
IAS 2009 - Cape Town
Nofemela, A
Characterization of genotypic properties of transmitted HIV-1 variants across different subtypesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Nofemela, A
Genetic characterization of transmitted HIV-1 env variants from Mbeya, TanzaniaUse SHIFT+ENTER to open the menu (new window).
Abstract: 3rd Annual South African AIDS Conference, 2009, Durban
Ouma, B
Evolution of Autologous Neutralizing Antibody Responses in Subjects Infected with HIV-1 Subtype D in Rakai District, UgandaUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Ren, Li
Neutralization of HIV-1 cell-cell spreadUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Revilla, A
Improved Protocol for Amplification from Plasma and Cloning of Functional Full-length Envelopes of Different Genetic Forms of HIV-1Use SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Revilla, A
Development of a panel of functional HIV-1 subtype G full-length envelope clones obtained from plasma of infected individualsUse SHIFT+ENTER to open the menu (new window).
International AIDS Society 2009 - Cape Town
Robinson, JE
Human and Rhesus MAbs Recognizing Distinct Groups of Epitopes that Elicit Neutralizing Antibodies against Autologous HIV-1 StrainsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Salazar, M
Identification and Chemical Synthesis of a Complete Infectious Transmitted HIV-1 GenomeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Salazar-Gonzalez, JF
Identification of Transmitted/Founder Complete HIV-1 Genomes in Subjects With Acute HIV-1 InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Sarzotti-Kelsoe, M
Evaluation and Recommendations on Good Clinical Laboratory PracticeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Shen, X
A Mutation in HIV-1 gp41 Envelope Membrane Proximal Region Increases Neutralizing Antibody Potency and in the Context of Peptide-Lipid Conjugates Binds to 2F5 mAb more StablyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Todd, CA
Development and Implementation of an International Proficiency Testing Program for a Neutralizing Antibody Assay for HIV-1 in TZM-bl CellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Wieczorek, L
HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specificUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Yates, NL
Differential Regulation of HIV-Specific IgG Subclass Antibodies Following Infection Versus VaccinationUse SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting - Boston
Expand/Collapse CAVD Grantee : Pantaleo VDC ‎(6)
David, D
Assay conditions with primary HIV-1 isolates giving neutralization rates proportional to Ab concentration and in vivo protectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Delaloye, J
Role of Toll-like receptor (TLR), RIG-I-like receptor (RLR) and Nod-like receptor (NLR) pathways in innate immune responses elicited by poxvirusUse SHIFT+ENTER to open the menu (new window).
Toll 2008 - Lisbon
Kibler, K
Replication competent attenuated strains of vaccinia virus as potential vaccine vectors.Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Kibler, KV
Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccinesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Köstler, J
HIV-1 Vaccine Design based on Human Vaccine Trials to Improve Gag, Pol, Nef and Env Specific Immune ResponsesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Quakkelaarm ED
Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitroUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Patterson VDC ‎(11)
Athanasopoulos, T
Ubiquitination and segmentation of HIV genetic components: Aiming towards an HIV vaccine inducing broad(er) T cell immune responsesUse SHIFT+ENTER to open the menu (new window).
European Society for Gene and Cell Therapy 2008 - Brugge
Athanasopoulos, T
Assessment of adenoviral vectors expressing HIV genetic components: Aiming towards a thermo-stable HIV vaccine inducing broad T cell immune responsesUse SHIFT+ENTER to open the menu (new window).
British Society for Gene Therapy 2009 - London
Bachy, V
A vaccination strategy harnessing the adjuvanticity of skin dendritic cells with modified adenoviral vectorsUse SHIFT+ENTER to open the menu (new window).
Society for General Microbiology 2009 - Harrogate
Bachy, V
Development of a 'Stealth' Adenovirus Vaccine VectorUse SHIFT+ENTER to open the menu (new window).
British Society for Gene Therapy 2008 - Edinburgh
Bachy, V
Harnessing skin dendritic cells as a vaccination strategyUse SHIFT+ENTER to open the menu (new window).
Europrise 2008 - Malta
Benlahrech, A
Adenovirus Vectors Induce Expansion of Memory CD4 T Cells with a Mucosal Homing Phenotype that are Readily Susceptible to HIV-1 InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Benlahrech, A
Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
El-Doueik, H
Development of a "Stealth" Adenovirus vaccine vectorUse SHIFT+ENTER to open the menu (new window).
Keystone Meeting 2008 - Banff
Harris, JD
Assessment of Adenoviral Vectors in Gel Formulations for the Manufacture of Micro-Needle Skin PatchesUse SHIFT+ENTER to open the menu (new window).
European Society of Gene and Cell Therapy 2007 - Rotterdam
Papagatsias, T
Using Ubiquitin Fusion to Augment Immune Responses Against HIV-1 AntigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Papagatsias, T
Using Ubiquitin Fusion to Augment Immune Responses Against HIV-1 AntigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Plummer GCGH ‎(2)
Herman, M
Optimization of the Expansion of Antigen-Specific CD8+ T-cells for Use in a Viral Suppression AssayUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Richmond, M
Epitope mapping of HIV-specific CD8+ T cell responses by polyfunctional flow cytometry and proliferation responses reveal distinct specificity defined by functionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Reinherz VDC ‎(1)
Song, L
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interfaceUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Self VISC ‎(2)
Bellew, M
LabKey Software: An Open-Source Repository and Portal for Lab and Clinical DataUse SHIFT+ENTER to open the menu (new window).
BioIT Conference 2008 - Vancouver
Moodie, Z
Statistical Approaches to Analyze Multi-parametric Flow AnalysisUse SHIFT+ENTER to open the menu (new window).
BioIT Conference 2008 - Vancouver
Expand/Collapse CAVD Grantee : Stamatatos VDC ‎(16)
Ban, YA
4e10 epitope-scaffolds mimic the antibody-bound epitope conformationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Carrico, C
A Computationally Designed Immunogen Elicits Potent Anti-V3 Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Klein, JS
Examination of size and avidity in the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10Use SHIFT+ENTER to open the menu (new window).
Keystone 2009
Robinson, JE
Human and Rhesus MAbs Recognizing Distinct Groups of Epitopes that Elicit Neutralizing Antibodies against Autologous HIV-1 StrainsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Sather, DN
Determinants of Cross-reactive neutralizing antibody responses developed during natural HIV-1-infectionUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Schief, B
Computational Design of Immunogens to ‘Re-elicit’ Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
American Crystallographic Association Meeting 2009 - Toronto
Schief, WR
Computational design of non-HIV protein scaffolds presenting conserved HIV-1 neutralization epitopesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2006 - Amsterdam
Schief, WR
Advances in Vaccine ScaffoldsUse SHIFT+ENTER to open the menu (new window).
CROI 2008 - Boston
Sellhorn, G
Expression, purification and antigenic characterization of soluble clade A/B heterotrimeric gp140 Envelope glycoproteins from HIVUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Sellhorn, G
Engineering and characterization of soluble heterotrimeric gp140- Envelope glycoproteins from HIVUse SHIFT+ENTER to open the menu (new window).
Keystone 2007
Sellhorn, G
Engineering, expression and antigenic and immunogenic characterization of novel soluble clade A/B heterotrimeric gp140-Envelope glycoproteins Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Strong, RK
Masking of MPER Epitopes through Self-AssociationsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Wallace, A
Engineering and characterization of soluble heterotrimeric gp140-Envelope glycoproteins from HIVUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Xu, C
Production, Biophysical Characterization and Structure Determination of Computationally Derived HIV gp140 Epitope-Scaffolds Use SHIFT+ENTER to open the menu (new window).
11th Annual Joint Research Sympoisum 2007 - Seattle
Xu, H
Putative Lipid-phosphate Head Group Binding Site on the Broadly Neutralizing Anti-HIV Antibody 4E10Use SHIFT+ENTER to open the menu (new window).
Keystone 2009
Xu, H
The Specific Phospholipid Binding and Neutralizing Activities of the Anti-HIV Antibody 4E10 are SeparableUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : von Briesen HSC ‎(17)
Durst, C
ChameleonLab®: A laboratory knowledge and workflow management system based on low temperature electronicsUse SHIFT+ENTER to open the menu (new window).
WOLTE 2008 - Ilmenau, Germany
Fuchs, CC
Development of a 32-bit microcontroller-based cryotank backplane system for use in the "Global HIV Vaccine Research Cryorepository"Use SHIFT+ENTER to open the menu (new window).
WOLTE 2008 - Ilmenau, Germany
Germann, A
Global HIV Vaccine Research Cryorepository – GHRCUse SHIFT+ENTER to open the menu (new window).
2nd Global Vaccine Congress 2008 - Boston
Germann, A
Global HIV Vaccine Research Cryorepository – GHRCUse SHIFT+ENTER to open the menu (new window).
German Society for Virology 2009 - Leipzig
Germann, A
UnknownUse SHIFT+ENTER to open the menu (new window).
19th Annual Meeting of the Society for Virology 2009 - Leipzig
Ihmig, FR
Development of electronic cryovials and electronic cryotank modules for the "Global HIV Vaccine Research Cryorepository"Use SHIFT+ENTER to open the menu (new window).
WOLTE 2008 - Ilmenau, Germany
Koch, S
Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
German Society for Virology 2009 - Leipzig
Koch, S
Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Koch, S
Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
19th Annual Meeting of the Society for Virology 2009 - Leipzig
Koch, S
Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
IAS 2009 - Cape Town
Meyerhans, A
The "Global HIV Vaccine Research Cryorepository": Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
German-Japanese AIDS Konferenz 2009 - Bochum
Schulz, J
Standardized serum-free cryomedia have minimum cytotoxicity and maintain antigen-specific T-cell responseUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Schulz, JC
Development and application of new storage-technologies for effective and secure cryobankingUse SHIFT+ENTER to open the menu (new window).
Medical Physics and Biomedical Engineering 2009 - Manchen
Schulz, JC
Development and application of new storage-technologies for effective and secure cryobankingUse SHIFT+ENTER to open the menu (new window).
Medical Physics and Biomedical Engineering World Congress 2009 - Munich
Schulz. JC
New modular HIV-cryosubstrates for secure and reliable sample identification and DMSO reduction in cryopreserved peripheral blood mononuclear cellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Shirley, SG
A large-scale cryo-electronic system for biological sample bankingUse SHIFT+ENTER to open the menu (new window).
WOLTE 2008 - Ilmenau, Germany
von Briesen, H
Global HIV Vaccine Research Cryorepository - GHRCUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Expand/Collapse CAVD Grantee : Walker VDC ‎(39)
Addo, M
Increased Tim-3 expression on T cells in chronic HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Allen, T
Ultra-Deep Sequencing of Full-Length HIV-1 Genomes Identifies Rapid Viral Evolution During Acute InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Altfeld, M
Immune recognition of HIV-1 during acute infection Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Angin, M
Regulatory T cell frequencies correlate with T cell activation in chronic HIV-1 infection (poster)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Arcary, Derseree
HIV-1 Subtype C Diversity in an Adult Cohort of Progressors and Non-progressors Using Single Genome AmplificationUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Boutwell, CL
CTL Escape Mutations in Gag Epitopes Restricted by Protective HLA Class I Alleles Cause Substantial Reductions in Viral Replication CapacityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Brumme, CJ
Reversion of HLA-associated polymorphisms in Gag, Pol and Nef during the first year of HIV infection: Sites, rates and pVL correlationsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Brumme, Z
Combined clinical and immunological biomarkers predict rates of CD4 decline in chronic untreated HIV infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Brumme, ZL
Relationship between HLA class I-driven evolution in Gag, Pol and Nef and clinical markers of HIV disease: a multi-center collaborative studyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Carrington M
Immunogenetic variation charaterizing exceptional control of HIVUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Carrington M
Immunogenetic effects on HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
Keystone Symposia on Human Immunology and Immunodeficiences 2009 - Beijing
Chang, JJ
TLR-mediated pDC responses to HIV-1 ligandsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
de Bakker, P
Genome-wide Association Analysis Use SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
de Bakker, P
A Genome-wide Association Study in HIV-1 Controllers Use SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
deBakker, Paul
A Genome-wide Association Study in HIV-1 Controllers Use SHIFT+ENTER to open the menu (new window).
NIH/OAR Genomic Analyses of HIV Infection 2009 - Bethesda
deBakker, Paul
Whole Genome Association Studies: Understanding the Genetic Basis of Susceptibility to Infectious DiseasesUse SHIFT+ENTER to open the menu (new window).
ASTMH 2008 - New Orleans
Dugast, AS
Dramatic changes in Fc-receptor expression during HIV-1 infection associated with reduced phagocytic activity during progressive HIV-1 infection (Poster)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Heckerman, David
Vaccine-induced Targeting of Epitopes Associated with Spontaneous Control of HIV Viral Replication is Associated with Lower Set-point Viral Loads in HIV-Infected Participants from the STEP TrialUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Henn, M
Ultra-deep Viral Sequencing Reveals Rapid CTL Escape and Reversion Events During Acute HIV-1 InfectionUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Henn, MR
Ultra-Deep Sequencing of Full-Length HIV-1 Genomes Identifies Rapid Viral Evolution During Acute Infection Use SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting 2009 - Boston
Jen, D
Comparative Viral Genome Visualization (Poster)Use SHIFT+ENTER to open the menu (new window).
IEEE Information Visualization Conference (IEEE InfoVis) - Atlantic City
Julg, B
Polyvalent Gag-specific CD8 T-cells with enhanced functional properties are enriched in HIV-1 clade C infected individuals with lower viral loads Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Kavanagh, DG
Unique spectrum of pro-and anti-inflammatory molecules induced on DCs by simultaneous stimulation with TLR8 plus TLR3 or TLR4 ligandsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Kwon, D
new technologies to better understand spontaneous control of HIV (Oral Presentation)Use SHIFT+ENTER to open the menu (new window).
Unlocking the Mystery of the HIV Controller Symposium 2009 - San Francisco
Kwon, DS
The Role of CD4+ CD25+ Regulatory T Cells in the Control of IL-10 Mediated T cell Impairment in Chronic HIV InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Lazaro, E
The intracellular production of HIV antigenic peptides is guided by predictable motifs and can be altered: implications for immunogen designUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Lazaro, E; Zhang SC
Predictable motifs guide the intracellular production of HIV antigenic peptidesUse SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting 2009 - Boston
Li, C
Reduced replication capacity of NL4-3 chimeric viruses encoding RT-Integrase sequences from HIV-1 elite controllers (poster)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Malboeuf, C
Capturing intra-host diversity of viral genomes using “next-generation” sequencing technology Use SHIFT+ENTER to open the menu (new window).
Next-Generation Sequencing Data Analysis 2009 - Providence RI
Nolting, A
MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunctionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Oniangue-Ndza, C
Impact of CTL Escape Mutations in HIV-1 Nef on Viral Replication (poster)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Pereyra, F
Epitope specific CD8+ T-cell responses predict spontaneous HIV virus replicationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Pyo, A
Skewed HIV-1-specific CD4+ Th2 helper cell contribution in progressive HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Schneidewind, A
Long-term Stability of Compensated CTL Escape Mutations following Acute HIV InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Schneidewind, A
Identification of Subdominant CD8+ Responses Selecting CTL Escape Mutations in Gag that Impair HIV ReplicationUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Skaria, Amy
Compartmentalization of Drug Resistance, Immune Escape, and Co-receptor Tropism in Circulating Plasma Viruses during Late-stage HIV InfectionUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Streeck, H
The first emerging CD8 T cell responses are a major determinant of early viral set pointUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Streeck, H
Impairment of HIV-1-specific CD8+ T cell function by soluble epithelial adhesion molecules Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Streeck, H; Kwon, DS
The epithelial adherens junction protein E-cadherin inhibits HIV-1-specific CD8+ T cell responses by binding to KLRG1 Use SHIFT+ENTER to open the menu (new window).
International Congress of Mucosal Immunology 2009 - Boston
Expand/Collapse CAVD Grantee : Weiss VDC ‎(9)
Balla-Jhagjhoorsingh, S
New neutralizing monoclonal antibodies from HIV-1 subtype C and CRF02_AG infected peopleUse SHIFT+ENTER to open the menu (new window).
Ehrlich 2008 - Germany
Balla-Jhagjhoorsingh, S
The importance of well-defined HIV-1 neutralization assaysUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Benen, T
An HIV-1-based screening platform for selection of envelopes with high affinity for broadly neutralizing antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Bruun, TH
Cell-surface Display and Panning of HIV-1 derived Envelope proteinsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Hinz, A
Immunogenicity and Neutralization Properties of a Trimeric MPER Containing gp41 AntigenUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Isaksen, A
Neutralisation activity in a geographically diverse East London cohort of HIV-1 infected patientsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Jhagjhoorsingh, SB
Strong and potent neutralizing IgG memory B cells in HIV-1 subtype C and CRF02_AG infected individualsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Schilling, K
Generation of a HI-viral packaging cell line as scaffolding for a lentiviral display systemUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Weiss, RA
Llama antibody fragments with broad HIV-1 crossneutralizing activityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Expand/Collapse CAVD Grantee : Zolla-Pazner VDC ‎(19)
Agarwal, A
Structural Model of gp120 Surface of Infection Based on Positional Charge Differences between X4- and R5-tropic virusesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Alam, SM
HIV-1 Env gp41 Abs that mask neutralizing epitopes - production in HIV-1 infection and potential for reg of gp41 MPER NAbsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Almond, D
Dynamic Characterization of the V3 Loop CrownUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Almond, D
Sequence variability in the crown of the V3 loop of the HIV-1 envelope is clustered within a small 3D structural zone Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Burda, S
Evolution of HIV-1 subtype B viruses and neutralization patterns with heterologous anti-HIV-1 antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Burke, V
Structural Characterization of Neutralizing Human Anti-V3 Monoclonal Antibodies 3074 and 268-DUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Cardozo, T
Structural Basis for Coreceptor Selectivity by the HIV Type 1 V3 LoopUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Cardozo, T
Worldwide epitope prevalence of crystallographically resolved anti-V3 antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Gorny, MK
Immunoglobulin Gene Usage by Neutralizing Human Anti-V3 HIV-1 Monoclonal Antibodies Derived from Clade B and Non-B HIV-1-infected IndividualsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Gorny, MK
Human anti-V3 monoclonal antibodies (mAbs) from non-clade B-infected individuals display cross-clade neutralizationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Gorny, MK
Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Jiang, X
Structural Basis of the Antibody-Antigen Interaction in Human Anti-V3 HIV-1 Monoclonal AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Jiang, X
Crystal Structures of HIV-1 Neutralizing Anti-V3 Monoclonal Antibody 2557 in Complex with V3 PeptidesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Jiang, Xunqing
Molecular design of a mimotope that preserves conserved structural elements of the HIV-1 V3 crownUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Krachmarov, C
Effects of V3 Variation and V1-V2 Masking on Neutralization on a Panel of Tier 2 Clade B Envs by V3-Specific MAbs and PAbsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Zolla-Pazner, S
Induction of Cross-clade, Anti-V3 Neutralizing Antibodies in Rabbits Using a DNA Prime/Protein Boost Immunization RegimenUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Zolla-Pazner, S
Focusing the Immune Response on the V3 Loop of the HIV-1 gp120 Envelope Induces Cross-Clade Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Zolla-Pazner, S
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Zolla-Pazner, S
Induction of Cross-clade Neutralizing Antibodies with a Prime/Boost Vaccine Strategy Focused on a Neutralizing EpitopeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris